Solid Biosciences (SLDB) Non Operating Income (2017 - 2024)
Historic Non Operating Income for Solid Biosciences (SLDB) over the last 7 years, with Q4 2024 value amounting to -$2.7 million.
- Solid Biosciences' Non Operating Income fell 24002.07% to -$2.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.0 million, marking a year-over-year decrease of 3892.19%. This contributed to the annual value of $5.0 million for FY2024, which is 3892.19% down from last year.
- Per Solid Biosciences' latest filing, its Non Operating Income stood at -$2.7 million for Q4 2024, which was down 24002.07% from $2.5 million recorded in Q3 2024.
- Solid Biosciences' Non Operating Income's 5-year high stood at $19.4 million during Q4 2022, with a 5-year trough of -$2.7 million in Q4 2024.
- For the 4-year period, Solid Biosciences' Non Operating Income averaged around $2.3 million, with its median value being $1.9 million (2023).
- Its Non Operating Income has fluctuated over the past 5 years, first soared by 66344.83% in 2023, then plummeted by 24002.07% in 2024.
- Solid Biosciences' Non Operating Income (Quarter) stood at -$16000.0 in 2020, then soared by 121443.75% to $19.4 million in 2022, then tumbled by 90.06% to $1.9 million in 2023, then crashed by 240.02% to -$2.7 million in 2024.
- Its last three reported values are -$2.7 million in Q4 2024, $2.5 million for Q3 2024, and $2.7 million during Q2 2024.